Does Dr. SAKINA ABOWATH have financial conflicts of interest?

Dr. SAKINA ABOWATH (P.A.) has received a total of $6,081 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $6,081 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SAKINA ABOWATH?

According to CMS Open Payments data, Dr. SAKINA ABOWATH received funding from REGENERON HEALTHCARE SOLUTIONS ($1,592), GENZYME CORPORATION ($1,361), and INCYTE CORPORATION ($902).

Does Dr. SAKINA ABOWATH receive research grants or speaking fees?

Dr. SAKINA ABOWATH has received $6,081 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SAKINA ABOWATH

P.A.Real-Time Hydrated

Specialty: Physician Assistant, Medical

Practice Location: DIAMOND BAR, CA 91765

NPI Number: 1326287525

LIFETIME INDUSTRY VALUE

$6,081

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABOWATH is a verified Physician Assistant, Medical practitioner based in DIAMOND BAR, CA.

Between 2021 and 2024, Dr. ABOWATH had an overall industry promotional and research financial footprint of $6,081 as recorded in the federal CMS Open Payments database.

$6,081 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABOWATH's primary funding source is REGENERON HEALTHCARE SOLUTIONS, which accounts for $1,592 (representing 26.2% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

REGENERON HEALTHCARE SOLUTIONS

Rank 1

$1,592

26.2%

GENZYME CORPORATION

Rank 2

$1,361

22.4%

INCYTE CORPORATION

Rank 3

$902

14.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.